Skip to main content
SpringerLink
Log in

Drug-Induced Headache

  • Conference proceedings
  • © 1988

Overview

Editors:
  1. Hans-Christoph Diener

    1. Department of Neurology, University of Tübingen, Tübingen, Germany

    View editor publications

    You can also search for this editor in PubMed   Google Scholar

  2. Marcia Wilkinson

    1. The City London Migraine Clinic, London, UK

    View editor publications

    You can also search for this editor in PubMed   Google Scholar

Part of the book series: Advances in Applied Neurological Sciences (NEUROLOGICAL, volume 5)

This is a preview of subscription content, log in via an institution to check access.

Access this book

Log in via an institution
eBook USD 84.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book USD 109.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Other ways to access

Licence this eBook for your library

Institutional subscriptions

Table of contents (21 papers)

  1. Front Matter

    Pages I-VII
    Download chapter PDF

  2. Introduction

    1. Introduction

      • M. Wilkinson
      Pages 1-2

  3. Clinical Aspects of Drug-Induced Headache

    1. Front Matter

      Pages 3-3
      Download chapter PDF

    2. Daily Chronic Headache — Tension Headaches, Migraine, and Combined Headaches: The Transformation Concept

      • J. R. Saper
      Pages 5-7

    3. Clinical Manifestations of Excessive Use of Analgesic Medication

      • J. Dichgans, H.-C. Diener
      Pages 8-15

    4. Ergotism — The Clinical Picture

      • P. G. Andersson
      Pages 16-19

    5. Clinical and Epidemiological Observations on Drug Abuse in Headache Patients

      • G. Micieli, G. C. Manzoni, F. Granella, E. Martignoni, G. Malferrari, G. Nappi
      Pages 20-28

    6. Drug-Induced Headache — Does a Critical Dosage Exist?

      • E. Scholz, H.-C. Diener, S. Geiselhart
      Pages 29-43

    7. What Kind of Drugs Are Taken by Patients with Primary Headaches?

      • V. Pfaffenrath, U. Niederberger
      Pages 44-62

  4. Psychological, Behavioral, and Social Aspects of Drug-Induced Headache

    1. Front Matter

      Pages 63-63
      Download chapter PDF

    2. The Role of Behavioral and Social Factors in the Development of Drug-Induced Headache

      • W. D. Gerber, W. Miltner, U. Niederberger
      Pages 65-74

    3. Dependence on Analgesic Medication in Chronic Headache Sufferers: Psychological Analysis

      • P. Henry, J. F. Daubech, J. Lucas, M. Gagnon
      Pages 75-79

    4. Psychiatric Aspects of Drug Addiction of the Barbiturate-Alcohol Type

      • K.-L. Täschner, G. A. Wiesbeck
      Pages 80-84

  6. Treatment of Drug-Induced Headache

    1. Front Matter

      Pages 131-131
      Download chapter PDF
Back to top

Keywords

About this book

M. WILKINSON Patients with frequent or daily headaches pose a very difficult problem for the physician who has to treat them, particularly as many patients think that there should be a medicine or medicines which give them instant relief. In the search for the compound which would meet this very natural desire, many drugs have been manufactured and the temptation for the physician is either to increase the dose of a drug which seems to be, at any rate, partially effective, or to add one or more drugs to those which the patient is already taking. Although there have been some references to the dangers of overdosage of drugs for migraine in the past, it was not until relatively recently that it was recognized that drugs given for the relief of headache, if taken injudiciously, may themselves cause headache. The first drugs to be implicated in this way were ergotamine and phenazone. In the case of ergotamine tartrate, the dangers of ergotism were well known as this was a disorder which had been known and written about for many years. In the treatment of headache, fully blown ergotism is rare and in recent years has usually been due to self-medication in doses much greater than those prescribed although there are a few recorded cases where toxic amounts have been given.

Editors and Affiliations

  • Department of Neurology, University of Tübingen, Tübingen, Germany

    Hans-Christoph Diener

  • The City London Migraine Clinic, London, UK

    Marcia Wilkinson

Bibliographic Information

Publish with us

Policies and ethics

Back to top

Search

Navigation